WO2009154707A2 - System and method of evaluating a subject with an ingestible capsule - Google Patents
System and method of evaluating a subject with an ingestible capsule Download PDFInfo
- Publication number
- WO2009154707A2 WO2009154707A2 PCT/US2009/003533 US2009003533W WO2009154707A2 WO 2009154707 A2 WO2009154707 A2 WO 2009154707A2 US 2009003533 W US2009003533 W US 2009003533W WO 2009154707 A2 WO2009154707 A2 WO 2009154707A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- set forth
- marker
- capsule
- user
- plot
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/07—Endoradiosondes
- A61B5/073—Intestinal transmitters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/06—Devices, other than using radiation, for detecting or locating foreign bodies ; determining position of probes within or on the body of the patient
- A61B5/065—Determining position of the probe employing exclusively positioning means located on or in the probe, e.g. using position sensors arranged on the probe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/06—Devices, other than using radiation, for detecting or locating foreign bodies ; determining position of probes within or on the body of the patient
- A61B5/065—Determining position of the probe employing exclusively positioning means located on or in the probe, e.g. using position sensors arranged on the probe
- A61B5/066—Superposing sensor position on an image of the patient, e.g. obtained by ultrasound or x-ray imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14539—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring pH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/42—Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6861—Capsules, e.g. for swallowing or implanting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0247—Pressure sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/06—Devices, other than using radiation, for detecting or locating foreign bodies ; determining position of probes within or on the body of the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/06—Devices, other than using radiation, for detecting or locating foreign bodies ; determining position of probes within or on the body of the patient
- A61B5/061—Determining position of a probe within the body employing means separate from the probe, e.g. sensing internal probe position employing impedance electrodes on the surface of the body
Definitions
- the present invention relates generally to ingestible capsules and, more particularly, to a system and process for assisting a user in the evaluation of the gastrointestinal tract of a subject with an ingestible capsule.
- Ingestible capsules are well-known in the prior art. Such capsules are generally small pill-like devices that can be ingested or swallowed by a patient. It is known that such capsules may include one or more sensors for determining physiological parameters of the gastrointestinal tract, such as sensors for detecting temperature, pH and pressure. [0004] A number of methods of determining location of an ingestible capsule are known in the prior art. For example, it is known that signal strength or signal triangulation may be used to attempt to determine the location of an ingested capsule. However, the use of an RF signal has a number of disadvantages, including that it generally requires multiple antennas, various tissues may impact the signal differently, and patient movement may skew the results. It is also known that accelerometers may be used to attempt to determine location, but such methods also have disadvantages, such as drift, non-linear progression and rotational inaccuracy.
- the present invention provides a computerized method of analyzing measurements obtained from the gastrointestinal tract of subject comprising the steps of providing an ingestible capsule (20) having a sensor (22, 23, 24) for measuring a parameter of the gastrointestinal tract of a subject, having a subject ingest (118) the capsule, recording (130) measurements from the sensor as the capsule passes through the gastrointestinal tract of the subject, transmitting (131, 122) the measurements to a processor (31), conditioning (132) the measurements to provide data as a function of a time interval, plotting (133) the data on a display (32), providing a query (205, 216, 234) on the display, receiving input (207, 218, 237) from a user in response to the query, setting a marker (50-53) on the plot (40) at a location as a function of the input, and determining (238) a capsule transit time for a
- the sensor may be selected from a group consisting of a pH sensor (22), a pressure sensor (23) and a temperature sensor.
- the step of transmitting the measurements to a processor may comprise the steps of transmitting the measurements from the capsule to a receiver (17), and downloading the measurements from the receiver to the processor.
- the step of conditioning the measurements to provide data as a function of a time interval may comprise the steps of screening the measurements to verify that they are valid.
- the plot may be a graph (40).
- the step of providing a query may comprise the steps of showing a suggested marker on the plot at a location and seeking confirmation from the user that the suggested marker is at a desired location (205, 216, 234).
- the input may comprise confirmation by the user that the suggested marker is at the desired location (207a, 218a, 237a).
- the step of providing a query may comprise the steps of showing a suggested marker on the plot at a location and allowing the user to move the suggested marker by way of an input device 33 communicating with the processor (207b, 218b, 237b).
- the input may comprise movement of the suggested marker by the user with the input device.
- the step of providing a query may comprise the step of allowing the user to position a marker at a desired location on the plot with an input device communicating with the processor and the input may comprise placement of the marker by the user with the input device.
- the data may be plotted in a first color and the marker may be shown on the plot in a second color different from the first color.
- the location of the marker on the plot may correspond to an event selected from a group consisting of ingestion (50), gastric emptying (51), colonic entry (52), and body exit (53).
- the transit time may be selected from a group consisting of gastric emptying time, small bowel transit time, colonic transit time, whole gut transit time, and oral caecal transit time.
- the transit time may be displayed on the display.
- the method may further comprise the step of comparing the transit time to a standard transit time and a result of the comparison may be displayed on the display.
- the method may further comprise the step of comparing the data to a standard, and the standard may be selected from a group consisting of stomach pH, pH rise from stomach to small bowel, pressure in a portion of the gastrointestinal tract, and a temperature fluctuation.
- the method may further comprise the steps of recording an event (134) associated with the subject during transit of the capsule, correlating the event with the data (201), and notating the event on the plot (202).
- the event may be selected from a group consisting of the subject ingesting the capsule, ingesting food, ingesting liquid, experiencing pain, experiencing nausea, experiencing gas, experiencing bloating, exercising, moving actively, vomiting, resting, waking up, and experiencing a bowel movement.
- the method may further comprise the step of entering a notation or comments associated with the plot (204).
- a computer-readable medium having computer- executable instructions for performing a method comprising receiving measurements of a parameter of a gastrointestinal tract of a subject recorded by a sensor on an ingestible capsule ingested by the subject, conditioning the measurements to provide data as a function of a time interval, plotting the data on a display, providing a query on the display, receiving input from a user in response to the query, setting a marker on the plot at a location as a function of the input, and determining a capsule transit time for a selected portion of the gastrointestinal tract as a function of the location of the marker.
- a system for analyzing measurements obtained from the gastrointestinal tract of a subject comprising an ingestible capsule having a sensor adapted to record measurements as the capsule passes through at least a portion of a subject's gastrointestinal tract, a receiver adapted to receive the measurements when transmitted from the capsule, a processor adapted to communicate with the receiver, a display in communication with the processor, an input device in communication with the processor, the processor programmed to receive the measurements, condition the measurements to provide data as a function of a time interval, plot the data on the display, provide a query on the display, receive input from the input device in response to the query, set a marker on the plot at a location as a function of the input, and determine a capsule transit time for a selected portion of the gastrointestinal tract as a function of the location of the marker.
- the general object is to provide a method for assisting a user in the evaluation of a subject.
- Another object is to provide a method for guiding a user in evaluating a subject.
- Another object is to provide a system for guiding a user in evaluating a subject.
- Fig. 1 is a sectional view of an ingestible capsule adapted to record pressure, pH and temperature measurements in a gastrointestinal tract.
- Fig. 2 is a schematic of an embodiment of the improved system.
- Fig. 3 is a flow chart of an embodiment of the improved method.
- Fig. 4A and Fig. 4B are a flow chart of the data analysis step shown in Fig. 3.
- Fig. 5 is a graphical display of data with markers applied.
- the terms “horizontal”, “vertical”, “left”, “right”, “up” and “down”, as well as adjectival and adverbial derivatives thereof simply refer to the orientation of the illustrated structure as the particular drawing figure faces the reader.
- the terms “inwardly” and “outwardly” generally refer to the orientation of a surface relative to its axis of elongation, or axis of rotation, as appropriate.
- system 15 generally includes an ingestible capsule 20 having a pressure sensor assembly 23 for taking pressure measurements of a subject's gastrointestinal tract, a pH sensor 22 for taking pH measurements of a subject's gastrointestinal tract, and a transmitter 16 for transmitting the measurements, a receiver 17 for receiving signals sent from transmitter 16, and a workstation 19 for processing measurements from sensors 22 and 23.
- capsule 20 is an elongated ellipsoid-shaped device, somewhat resembling a medicament capsule.
- the capsule generally has a hard shell or casing which houses the transmitting electronics, battery compartment and sensors.
- Capsule 20 is adapted to be ingested or otherwise positioned within a tract to sense pressure, pH and temperature within the tract and to transmit such readings.
- capsule 20 is generally a cylindrical member elongated about axis y-y and having generally rounded closed ends.
- the capsule is generally provided with an outer surface to facilitate easy swallowing of the capsule.
- capsule 20 is an autonomous swallowable capsule and is self- contained. Thus, capsule 20 does not require any wires or cables to, for example, receive power or transmit information.
- the pH, pressure and temperature data are transmitted from within the GI tract to data receiver 17.
- Capsule 20 includes a pressure sensor assembly 23 comprising a flexible sleeve 26 affixed to the shell of the capsule and defining a chamber 28 between the shell and the sleeve.
- a pressure sensor 29 is operatively arranged to sense pressure within chamber 28 and communicates with the chamber through a fluid port 30 at one end of the shell of the capsule. As shown, the pressure sleeve 26 of capsule 20 extends from a point below the middle of the capsule up over the top end of the capsule.
- pH sensor 22 On the opposite end of capsule 20 to pressure sensor 23 is pH sensor 22.
- pH sensor 22 is a conventional ISFET type pH sensor.
- ISFET stands for ion-selective field effect transistor and the sensor is derived from MOSFET technology (metal oxide screen field effect transistor).
- MOSFET metal oxide screen field effect transistor
- a current between a source and a drain is controlled by a gate voltage.
- the gate is composed of a special chemical layer which is sensitive to free hydrogen ions (pH). Versions of this layer have been developed using aluminum oxide, silicon nitride and titanium oxide. Free hydrogen ions influence the voltage between the gate and the source. The effect on the drain current is based solely on electrostatic effects, so the hydrogen ions do not need to migrate through the pH sensitive layer.
- the sensor is an entirely solid state sensor, unlike glass bulb sensors which require a bulb filled with buffer solution. Only the gate surface is exposed to the sample.
- capsule 20 senses and transmits measurements for at least 120 hours after activation.
- the range and accuracy of the sensors are generally 1 to 9.0 pH units with an accuracy of ⁇ 0.5 pH units, 0 to 350 mmHg with an accuracy of 5 mmHg, or 10% above 100 mmHg, and 25° to 49°C with an accuracy of ⁇ 1°C.
- the capsule transmits measurements at about 434 MHz and measures 26.8mm long by 1 1.7mm in diameter.
- portable data receiver 17 worn by the subject receives and stores measurements transmitted by transmitter 16 in capsule 20.
- Data receiver 17 contains rechargeable batteries and when seated in a docking station allows for battery charging and data download.
- Data receiver includes an internal processor and a small display window 18. Data is downloaded from data receiver 17 through a docking station via a USB connection to computer 19.
- computer 19 is a conventional Windows PC compatible laptop or desktop.
- personal computer 19 includes a processor 31 , data processing storage 34, a monitor or display 32, a user input device 33, and a printer 35.
- monitor 32 is a computer screen. However, monitor 32 may be any other device capable of providing an image or other data.
- user input device 33 includes a keyboard and a mouse. However, user input 33 could be a touch-sensitive display device, a control panel or any other suitable device for interfacing with data processor 31.
- the processing of the measurements from capsule 20 and the instructions for the user is generally provided using computer-executable instructions executed by a general- propose computer, such as a server or personal computer 19.
- a general- propose computer such as a server or personal computer 19.
- this processing may be practiced with other computer system configurations, including internet appliances, hand-held devices, wearable computers, multi-processor systems, programmable consumer electronics, network PCs, mainframe computers and the like.
- the term computer or processor as used herein refers to any of the above devices as well as any other data processor.
- processors are microprocessors, microcontrollers, CPUs, PICs, PLCs, PCs or microcomputers.
- a computer-readable medium comprises a medium configured to store or transport computer readable code, or in which computer readable code may be embedded.
- Computer-readable medium are CD- ROM disks, ROM cards, floppy disks, flash ROMS, RAM, nonvolatile ROM, magnetic tapes, computer hard drives, conventional hard disks, and servers on a network.
- the computer systems described above are for purposes of example only.
- An embodiment of the invention may be implemented in any type of computer system or programming or processing environment.
- it is meant to encompass processing that is performed in a distributed computing environment, were tasks or modules are performed by more than one processing device or by remote processing devices that are run through a communications network, such as a local area network, a wide area network or the internet.
- a communications network such as a local area network, a wide area network or the internet.
- processor is to be interpreted expansively.
- Processor 31 is programmed to interact with the user of system 15 and to guide the user in evaluating the gastrointestinal tract of a subject.
- Processor 31 provides step by step instructions to the user via monitor 32. With mouse 33 the user clicks on images or links on monitor 32 in response to questions or instructions.
- the user proceeds through a series of screens. The user indicates that each task has been completed by clicking a "Next" button at the bottom of each screen. Only when this input is provided does the system allow the user to continue on to the next task or step, thereby helping assure that no critical step is missed in the process.
- the user can be a physician, a physician's assistant, a veterinarian, or anyone who is administering or testing a subject.
- the method of this embodiment includes a number of general phases, including a setup phase 100, a calibration phase 1 12, a testing phase 1 16, an evaluation phase 120, and a documentation phase 128.
- setup phase 100 data receiver 17 is first turned on by pressing an "Event” button on the receiver.
- a receiver docking station is connected to processor 31 via a USB port and data receiver 17 is placed in the docking station.
- An audio signal lets the user know that processor 31 has recognized the USB connection to the data receiver.
- the system then instructs the user to enter information 103 about the subject undergoing the test via user interface 33.
- These fields may include name, date of birth, gender, height, weight and user name.
- Required information such as the name and date of birth of the subject, is marked with an asterisk.
- a "search for patient” button may be used to access existing records.
- certain contraindications for use are asked of the user, such as whether the subject has any implanted electro-mechanical devices, whether the subject has any GI obstructions, strictures or fistulas, whether the subject has a history of gastric bezoars, whether the subject has undergone GI surgery, whether the subject has difficulty swallowing, and whether the subject has Crohn's disease or diverticulosis. If one of these boxes is checked, a warning screen appears and the user may select to end the test or enter a justification for continuing and select to proceed. The "Next" button is not available until the user completes the contraindications step.
- Other questions that may be asked at this step include whether the subject is scheduled for an MRI in the following two weeks, whether the subject has taken motility medications, proton pump inhibitors, histamine2 blockers or antacids in the past 48 hours, whether the subject has had any abdominal surgery, whether the subject has any allergies, whether the subject is on any other medications, whether the subject is suffering with any medical symptoms, such as pain or constipation, and whether the subject smokes, is diabetic or pregnant.
- the user is prompted to select 104 a folder into which the test data is to be saved or stored. While the user may choose a folder to store the test records, a current default folder will be automatically selected, although the user may choose an alternative location.
- the user is then instructed 105 to ensure that the necessary parts of system 15 are ready for use. These parts include a capsule activation fixture, capsule 20 and its container, and a buffer. Each item is illustrated on monitor 32, and the user must check off each item before the "Next" button becomes available.
- the user is then instructed 106 on how to activate capsule 20, and these instructions may include illustrations.
- the user is instructed to place capsule 20 in its container on the power activation fixture 107, to properly align the capsule with the fixtures "On" mark and to press down on the container and hold for five seconds 108.
- the user is then instructed to remove the container from the activation fixture 109 and to then place the capsule in the docking station well.
- the user is then directed 112 to calibrate pressure sensor 23 and pH sensor 22.
- the user is directed 1 13 to enter a pressure calibration code found on the lid of the capsule container and the location of that code is shown.
- the user is then instructed with step by step illustrations to remove the lid of the container, to pour a pH calibration buffer into the capsule container 114, to remove the capsule from its seat by gently rocking it from side to side, and to then reinsert it into the container, with the pH sensor 110 degrees clockwise to the diamond-shaped window of the container.
- the capsule then automatically calibrates 1 15.
- the calibration is complete when the capsule pH reading remains stable at 6.0, and the message screen will change from "calibrating capsule” to "pH calibration complete”. Also, a status bar will change from red to green. The "test in progress" icon will then appear in the status bar.
- Capsule 20 is then used in testing phase 116 to measure parameters of the gastrointestinal tract of the subject.
- the user is directed to undock data receiver 17 and to position it on the subject using a lanyard or belt clip.
- the user is then instructed 117 to have the subject ingest a meal.
- a standard meal of an egg substitute two slices of bread and water is ingested.
- the user is instructed to remove the capsule from the buffer, to rinse it in water, and to have the subject ingest the capsule 1 18 with a half cup of water.
- the user is then asked to verify that the receiver and capsule are communicating by observing a solid black block to the right of the pH value on the display.
- a discharge checklist is then provided to the user and the user is instructed to check each instruction to the subject after it is given.
- the checklist includes the user reviewing the patient instruction sheet with the subject, reviewing the patient diary usage with the subject, scheduling a date for data receiver return, and providing the subject with physician/office contact information in case of emergencies and questions.
- the box next to each task on the discharge checklist must be checked before the user is able to click the "Finish" button.
- pH sensor 22 and pressure sensor 23 take measurements 130 and capsule 20 transmits 131 the measurements to receiver 17 being worn by the subject. The measurements are stored in receiver 17.
- an event button on receiver 17 allows the subject to electronically record a diary event 134, described further below, and to include a brief description of the event.
- the data is evaluated 120.
- the user dockets it in the docking station and the system automatically detects that there is data on the receiver 122 and displays a message asking if the user wishes to open the subject's previously created test file stored on computer 31. Once the subject's test file is open, the user is prompted to select "Download Data" and the download screen appears.
- the system conditions the downloaded measurements 132.
- the pressure data from the subject is conditioned to distinguish real contraction data from artifacts or "noise" within the data set, as well as to discount physiologically improbable values.
- both concerns are addressed as part of a process which inspects each data value in the pressure measurement data set provided by the capsule. Because the conditioning utilizes constant minimum and maximum threshold values to determine and eliminate data spikes and artifacts, the input pressure data is baseline compensated. As mentioned above, the pressure data is then conditioned by filtering out those sets of data points or contractions whose peaks are above a predetermined threshold or limit. In the preferred embodiment, this threshold is about 200 mmHg.
- the process considers a set of baseline compensated pressure measurements and begins evaluating each value in linear sequence from beginning to end. If a point is found to exceed the defined maximum, then the high value or spike is removed with its associated ascending and descending artifact values by traversing the data set both behind and ahead of the detected spike and zeroing the spike and any associated values, until either its termination or a new contraction is detected. The determination that an artifact has terminated is defined as any data point below a minimum pressure value.
- a pressure point is included in the calculation only if its value is greater than or equal to the sum of the baseline pressure and the minimum threshold and is below the sum of the baseline pressure and the maximum threshold.
- the conditioned data is then plotted 133 in graphical form 40 on screen 32 with a "Test Summary" overlay window.
- the software allows the user to selectively display pH versus time 60, pressure versus time 61 and temperature versus time 62 on the graph 40. The user may display these graphs separately or all three may be displayed in any combination or all together on the same graph. The user can also select to see just data from a specific region of the gastrointestinal tract of the subject.
- the system guides the user through a step-by-step analysis of the recorded data 123.
- the interactive analysis of the data includes a number of general steps, including matching subject diary events to the data 201, marking and confirming capsule ingestion 205, analyzing gastric pH baseline 208, identifying procedural violations such as the ingestion of an additional meal 212, marking and confirming gastric emptying 216, analyzing duodenal pH baseline 219, analyzing a pH change from the antrum to duodenum 223, determining rapid capsule emptying possibility 226, marking and confirming the ileo-cecal junction, marking and confirming body exit 234, and providing a complete test analysis 238, including segment transit times.
- the system first instructs 201 the user to match diary events recorded by the subject with the data recorded by capsule 20.
- the subject is directed to hit the event button on receiver 17 and record in a diary any events that may effect the data, such as the subject ingesting the capsule, the subject ingesting food, the subject ingesting a liquid, the subject experiencing abdominal pain or cramping, the subject experiencing nausea, the subject experiencing bloating or gas, the subject exercising or moving actively, the subject vomiting, the subject experiencing a bowel movement, the subject resting, and the subject waking up.
- a drop down menu of typical events is available to the user. The specific times that the event button on receiver 17 was pressed by the user are listed on the screen and the user is directed to select an event type from the menu 202 for each event.
- the user may also edit that description 203 if desired to more closely match it to the subject's written entries in the diary.
- the user may also enter notes 204 if desired. Annotating the graph with information from the subject's diary may help facilitate data analysis and interpretation. Thus, the user is allowed to select common events from the event icon drop down list or type in the user's own event caption and notes.
- System 15 instructs the user in marking and confirming on graph 40 a number of transitional events for the capsule as it passed through the gastrointestinal tract. These events include ingestion of the capsule or the ingestion event time (IET), the capsule emptying from the stomach or the gastric emptying time (GET), the capsule entering the colon or passing the ileo-caecal junction (ICJ), and the capsule exiting the body or body exit time (BET). These times and their confirmation then allow the program to calculate transit time through different portions of the gastrointestinal tract of the subject, including gastric emptying time, small bowel transit time, colonic transit time, whole gut transit time and oral caecal transit time.
- IET ingestion event time
- GET the capsule emptying from the stomach or the gastric emptying time
- ICJ ileo-caecal junction
- BET body exit time
- the program identifies the stomach region of the subjects gastrointestinal tract as the span of data between entry of the capsule into the stomach, and the emptying of the capsule into the bowels.
- the program identifies the antrum region of the gastrointestinal tract as the span of data starting half an hour before gastric emptying to the gastric emptying event.
- the program identifies the duodenal region of the gastrointestinal tract as the span of data starting from gastric emptying to one half hour after gastric emptying.
- the small and large bowel region of the gastrointestinal tract are identified as being the span of data between gastric emptying and capsule body exit, differentiated by passage through the ICJ.
- the first marker applied indicates the time the subject ingested the capsule or the IET.
- the user is instructed to confirm the time of capsule ingestion 205.
- System 15 performs its own computation for the IET and provides this information to the user 206 by placing a suggested marker 50 on graph 40.
- the information may also be provided by showing the coordinates.
- the user is then provided the option of agreeing and confirming 207a the suggested IET, or the user may disagree and move the marker to a different location 207b on graph 40.
- the computed IET characterizes the ingestion event as two distinct event points: the point in time at which the capsule is swallowed by the subject, and the point in time in which the capsule enters the stomach. This distinction is made for the purpose of computational accuracy.
- the first point is used to track the beginning and duration of the test itself relative to the activation of the capsule and the physical act of being swallowed, whereas the second is used in conjunction with the algorithm which analysis the values for pH, temperature and pressure. Both points are found and used, but are maintained and referenced differently.
- the typical pH profile for the beginning of the test is characterized by the calibration phase, followed by a period of exposure to air, and concluded by a gastric phase. The calibration period is defined as the beginning of the test when pH values are at 6.0.
- the gastric phase is identified by a sustained drop in pH values to well below the calibration value, generally between 1.0 and 4.0.
- the system first determines the average temperature across an entire test to establish baseline body temperature. The point within the temperature data set at or above the average is found, and the corresponding pH data point is found and used throughout the remainder of the program as a potential capsule stomach entry point. The program then proceeds to search the pH data set below the first value in the pH value set and this potential stomach entry point to locate a maximum pH value. The maximum value is then used as a boundary point.
- the pH minimum located between the beginning of the data set and the maximum point is defined as the physical swallow of the capsule.
- the pH minimum located between the potential stomach entry point and the pH maximum point becomes the final stomach entry point.
- the user is then asked to analyze the gastric pH baseline 208.
- a baseline below 4 indicates normal acidic conditions and a baseline above 4 may need further characterization.
- the user is asked 209 whether gastric pH reached a baseline below 4. If the user response 214 is "No", a default annotation is inserted 211 into the "Notes” box indicating that a stomach pH below 4 was not observed. This annotation may be edited or comments and observations added by the user by typing in the "Notes” box. If the user answers "Yes", the user is instructed to proceed to the next step.
- the user is then asked about any procedural deviations, particularly whether the subject had any additional meals within 6 hours of ingestion 212.
- the subject eating additional meals before 6 hours has elapsed can affect the validity of the test result.
- An additional meal is defined as anything other than limited quantities of water. Since snacks or meals should be recorded in the patient diary with an event notation, this information is used to provide analysis 212.
- the user is asked 213 to check the event history and whether the subject ate an additional meal within 6 hours of ingestion. If the user responds 214 "Yes", a corresponding marker is indicated 215 on graph 40. In this embodiment, the user is asked to insert this meal marker with a point annotation on graph 40.
- the program also reminds the user that the additional meal would not include the standard meal at the start of the test.
- additional markers may be used to identify the time of each meal on graph 40.
- the user is instructed to confirm the time of gastric emptying 216.
- System 15 performs its own computation for GET and provides this information to the user 217 by placing a suggested marker 51 on graph 40. The information may also be provided by showing the coordinates.
- the user is then provided the option of agreeing and confirming 218a the suggested GET, or the user may disagree and move the marker to a different location 218b on graph 40.
- the gastric emptying time is the elapsed time between ingestion of the capsule and the start of a sustained pH rise.
- the pH profile of gastric emptying is typically characterized by a sharp rise in pH from very low values, followed by a slight drop, and concluded by a substained pH at around neutral value. This corresponds with the exit of the capsule from the highly acidic environment of the stomach into the small bowel, where pH is at a neutral level for healthy subjects.
- the sustained pH rise typically will have no transient drops longer than ten minutes that exceed 50% of the pH change observed during the pH rise.
- To compute GET the program looks at the data collected in reverse, starting at the end of the test and working towards the beginning of the test.
- the software detects gastric emptying by first filtering the pH profile to exclude predefined, physiologically improbably values and adjusting the raw data against the test's maximum and minimum to provide a more uniform trend, for the purpose of eliminating multiple artifact point that may result in a false reading. After filtration, the pH data set is traversed backwards to locate the demarcation between the sustained pH values of the bowel area and the small spike that immediately follows gastric emptying. After the stomach-bowel transition point is found, the data is then analyzed from the post-emptying spike to the next sustained low pH reading for a sharp sustained drop in the pH slope. The beginning point of the drop, with respect to the low (stomach) pH portion of the slope, is used as the point of gastric emptying and a suggested marker 51 is applied.
- the pH data may be further analyzed with the user by looking closely at the duodenal pH baseline 219 and the pH change from the antrum to the duodenum 223.
- the user is asked 220 whether the rise in pH is sustained within 30 minutes after the indicated 51 GET. If the user selects 221 "No", a note is automatically entered 222 on graph 40 indicating that the duodenal pH baseline was not observed. If the user answers "Yes", the user is instructed to proceed to the next step.
- the pH change from the antrum to the duodenum is then analyzed 223.
- the pH baseline 30 minutes before emptying is shown to the user
- the pH baseline 30 minutes after emptying is shown to the user 224
- the user is shown the median pH in the antrum and the duodenum 224.
- the user is also instructed that typically a pH rise of 3 should be observed between the two.
- the user is requested to accept the pH change 225a and proceed to the next step or to select to have a note automatically inserted 225b on graph 40 indicating that an unusual pH difference was observed.
- the user is then requested to indicate whether a rapid capsule emptying appears to have occurred 226.
- the user is informed that rapid emptying of the capsule may be related to emptying of the test meal 227.
- the program calculates the duration of gastric emptying. Typically, a preliminary cutoff for a normal subject is 4 hours and the minimum cutoff for a valid test is 30 minutes.
- the user is asked 228 whether they observed an unexpected rapid emptying, or emptying occurring within 30 minutes of IET. If the user responds 229 "Yes", a note is automatically entered 230 on graph 40.
- the user is also asked whether the user observes an unexpectedly slow emptying, typically emptying occurring outside 6 hours. Again, if the user responds "Yes", a note to that effect is automatically shown on graph 40. This annotation may be supplemented with comments or edited by the user.
- a combined change in pH and motility index is used by the program to mark 52 the transition between the distal ileum and the caecum.
- a change in pH and a change in either frequency of contractions or motility index that correlates with variations in a template are used to compute the suggested ICJ 52, as further described in U.S. Patent Publication No. 2008/0064938, entitled "Method of Determining Location of an Ingested Capsule", the entire contents of which are incorporated herein my reference.
- the program may also prompt the user to comment on any notable pressure characteristics around the event time. These comments may also be displayed on graph 40 or included in the test summary if desired by the user.
- SBTT small bowel transit time
- BET body exit time
- System 15 performs its own computation for BET and provides this information to the user 235 by placing a suggested marker 53 on graph 40. The information may also be provided by showing the coordinates.
- the user is then asked to refer to the event markers and any indicated bowel movement event marker to corroborate the BET 236.
- the user is then provided the option of agreeing and confirming 237a the suggested BET, or the user may disagree and move the marker to a different location 237b on graph 40.
- BET is computed from a set of data trends as the capsule exits the body and is exposed to a non-physiological environment.
- a typical graph will show the pressure decreases to near zero or its calibrated offset and temperature drops sharply.
- the program uses temperature to determine BET.
- the system first determines a range of temperatures which represent body temperature using a pre-defined temperature of 32° C as a minimum threshold.
- the temperature data set is then inspected in reverse chronological order from the end of the test to locate the first data point which lies within the determined body temperature range and this is used.
- the pressure data set is analyzed in backwards chronological order for the first sharp rise in pressure values.
- the time of the detected pressure rise is then defined by the algorithm as the BET.
- CTT colonic transit time
- a standard CTT is shown to the user and the user is asked whether they observed an unexpected rapid or slow transit. If the user responds "Yes", a note is automatically entered on graph 40. This annotation may be supplemented with comments or edited by the user.
- TTT Whole gut transit time or total transit time (TTT) is the time from capsule ingestion to body exit and this may also be provided to the user for analysis in comparison to a standard.
- system 15 will also provide the user with a number of warnings or alerts during the process. If gastric emptying occurs within 30 minutes of capsule ingestion, a warning is provided to the user indicating that the test results are probably not valid. If a pH change of less than 3 units is indicated from the antrum to the duodenum, then the program provides the user with a warning that further clarification may be needed. If low voltage is detected in capsule 20, an alert is provided to the user. This alert advises the user to disregard or question all data collected after the start of the alert as the temperature readings may be artificially low.
- test analysis is completed 238.
- the user is informed that a test summary is available for display 239.
- the user is also given the chance to further edit any notes or annotations entered on graph 40.
- the user may then elect to finish the analysis, in which case the test summary appears 240 over graph 40.
- the test summary displays the subject transit times based on the user confirmed placement of markers 50-53.
- the test summary will also show the system computed transit times together with information regarding the transit times for a standard or healthy subject with respect to the indicated regions.
- gastric emptying time GET is shown and a standard of about 4 hours and under is indicated.
- Small bowel transit time SBTT, colonic transit time CTT and whole gut transit time TTT are also shown.
- the summary sheet may be reviewed by the user 124 on monitor 32.
- events recorded in the patient diary may be entered 125 on the summary sheet.
- the user may then generate a PDF version of the summary sheet or print the summary sheet 126 on printer 35.
- the information may be used to evaluate and diagnose the user 127.
- the user may generate billing or file documentation 128, including a reimbursement report 129 that is printable on printer 35.
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2009260834A AU2009260834B2 (en) | 2008-06-18 | 2009-06-12 | System and method of evaluating a subject with an ingestible capsule |
CA2724890A CA2724890A1 (en) | 2008-06-18 | 2009-06-12 | System and method of evaluating a subject with an ingestible capsule |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13237908P | 2008-06-18 | 2008-06-18 | |
US61/132,379 | 2008-06-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009154707A2 true WO2009154707A2 (en) | 2009-12-23 |
WO2009154707A3 WO2009154707A3 (en) | 2010-04-01 |
Family
ID=41431929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/003533 WO2009154707A2 (en) | 2008-06-18 | 2009-06-12 | System and method of evaluating a subject with an ingestible capsule |
Country Status (4)
Country | Link |
---|---|
US (1) | US9538937B2 (en) |
AU (1) | AU2009260834B2 (en) |
CA (1) | CA2724890A1 (en) |
WO (1) | WO2009154707A2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013120184A1 (en) * | 2012-02-17 | 2013-08-22 | Micropharma Limited | Ingestible medical device |
AU2010235197B2 (en) * | 2009-03-31 | 2014-10-16 | Covidien Lp | Method of determining body exit of an ingested capsule |
US11007356B2 (en) | 2018-11-19 | 2021-05-18 | Progenity, Inc. | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9198608B2 (en) | 2005-04-28 | 2015-12-01 | Proteus Digital Health, Inc. | Communication system incorporated in a container |
US8730031B2 (en) | 2005-04-28 | 2014-05-20 | Proteus Digital Health, Inc. | Communication system using an implantable device |
CA2789262C (en) | 2005-04-28 | 2016-10-04 | Proteus Digital Health, Inc. | Pharma-informatics system |
US8912908B2 (en) | 2005-04-28 | 2014-12-16 | Proteus Digital Health, Inc. | Communication system with remote activation |
US8836513B2 (en) | 2006-04-28 | 2014-09-16 | Proteus Digital Health, Inc. | Communication system incorporated in an ingestible product |
US8802183B2 (en) | 2005-04-28 | 2014-08-12 | Proteus Digital Health, Inc. | Communication system with enhanced partial power source and method of manufacturing same |
AU2006251454A1 (en) * | 2005-05-24 | 2006-11-30 | Responsif Gmbh | Method for producing virus-type particles containing an active substance |
WO2007028035A2 (en) | 2005-09-01 | 2007-03-08 | Proteus Biomedical, Inc. | Implantable zero-wire communications system |
KR101568660B1 (en) | 2006-05-02 | 2015-11-12 | 프로테우스 디지털 헬스, 인코포레이티드 | Patient customized therapeutic regimens |
US8054140B2 (en) | 2006-10-17 | 2011-11-08 | Proteus Biomedical, Inc. | Low voltage oscillator for medical devices |
MY158019A (en) | 2006-10-25 | 2016-08-30 | Proteus Digital Health Inc | Controlled activation ingestible identifier |
US8718193B2 (en) | 2006-11-20 | 2014-05-06 | Proteus Digital Health, Inc. | Active signal processing personal health signal receivers |
JP5524626B2 (en) | 2007-02-01 | 2014-06-18 | プロテウス デジタル ヘルス, インコーポレイテッド | Ingestible event marker system |
CN103066226B (en) | 2007-02-14 | 2016-09-14 | 普罗透斯数字保健公司 | There is the in-body power source of high surface area electrode |
US8932221B2 (en) | 2007-03-09 | 2015-01-13 | Proteus Digital Health, Inc. | In-body device having a multi-directional transmitter |
US8115618B2 (en) | 2007-05-24 | 2012-02-14 | Proteus Biomedical, Inc. | RFID antenna for in-body device |
FI2192946T3 (en) | 2007-09-25 | 2022-11-30 | In-body device with virtual dipole signal amplification | |
US20100311026A1 (en) * | 2009-06-03 | 2010-12-09 | Tomes Jennifer E | Catheter Tray, Packaging System, and Associated Methods |
US8448786B2 (en) | 2009-06-30 | 2013-05-28 | Medline Industries, Inc. | Catheter tray, packaging system, instruction insert, and associated methods |
US9795761B2 (en) | 2009-06-30 | 2017-10-24 | Medline Industries, Inc. | Medical kit, packaging system, instruction insert, and associated methods |
US8678190B2 (en) | 2009-06-30 | 2014-03-25 | Medline Industries, Inc. | Catheter tray, packaging system, instruction insert, and associated methods |
US8631935B2 (en) | 2009-06-03 | 2014-01-21 | Medline Industries, Inc. | Catheter tray, packaging system, and associated methods |
CN104376659B (en) | 2008-03-05 | 2019-10-25 | 普罗透斯数字保健公司 | The ingestible event flag of multi-modal communications and system, and the method using it |
ES2696984T3 (en) | 2008-07-08 | 2019-01-21 | Proteus Digital Health Inc | Ingestion event marker data infrastructure |
CN104382598A (en) | 2008-08-13 | 2015-03-04 | 普罗透斯数字保健公司 | Method of producing a recognizer |
US8036748B2 (en) | 2008-11-13 | 2011-10-11 | Proteus Biomedical, Inc. | Ingestible therapy activator system and method |
CA2746650A1 (en) | 2008-12-11 | 2010-06-17 | Proteus Biomedical, Inc. | Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same |
US9439566B2 (en) | 2008-12-15 | 2016-09-13 | Proteus Digital Health, Inc. | Re-wearable wireless device |
TWI424832B (en) | 2008-12-15 | 2014-02-01 | Proteus Digital Health Inc | Body-associated receiver and method |
US9659423B2 (en) | 2008-12-15 | 2017-05-23 | Proteus Digital Health, Inc. | Personal authentication apparatus system and method |
CN102341031A (en) | 2009-01-06 | 2012-02-01 | 普罗秋斯生物医学公司 | Ingestion-related biofeedback and personalized medical therapy method and system |
JP5785097B2 (en) | 2009-01-06 | 2015-09-24 | プロテウス デジタル ヘルス, インコーポレイテッド | Pharmaceutical dosage delivery system |
WO2010111403A2 (en) | 2009-03-25 | 2010-09-30 | Proteus Biomedical, Inc. | Probablistic pharmacokinetic and pharmacodynamic modeling |
NZ619375A (en) | 2009-04-28 | 2015-03-27 | Proteus Digital Health Inc | Highly reliable ingestible event markers and methods for using the same |
WO2010132331A2 (en) | 2009-05-12 | 2010-11-18 | Proteus Biomedical, Inc. | Ingestible event markers comprising an ingestible component |
US8558563B2 (en) | 2009-08-21 | 2013-10-15 | Proteus Digital Health, Inc. | Apparatus and method for measuring biochemical parameters |
CN101711673B (en) * | 2009-10-16 | 2012-11-21 | 重庆金山科技(集团)有限公司 | System, device and method for wireless monitoring and positioning of pH value of esophagus |
TWI517050B (en) | 2009-11-04 | 2016-01-11 | 普羅托斯數位健康公司 | System for supply chain management |
UA109424C2 (en) | 2009-12-02 | 2015-08-25 | PHARMACEUTICAL PRODUCT, PHARMACEUTICAL TABLE WITH ELECTRONIC MARKER AND METHOD OF MANUFACTURING PHARMACEUTICAL TABLETS | |
EP2531099B1 (en) | 2010-02-01 | 2018-12-12 | Proteus Digital Health, Inc. | Data gathering system |
RU2012143791A (en) | 2010-04-07 | 2014-05-20 | Проутьюс Диджитал Хэлс, Инк. | MINIATURE INGESTED DEVICE |
TWI557672B (en) | 2010-05-19 | 2016-11-11 | 波提亞斯數位康健公司 | Computer system and computer-implemented method to track medication from manufacturer to a patient, apparatus and method for confirming delivery of medication to a patient, patient interface device |
US9474482B2 (en) | 2010-11-01 | 2016-10-25 | G-Tech Medical, Inc. | Method for diagnosis and treatment of disorders of the gastrointestinal tract, and apparatus for use therewith |
US10499829B2 (en) | 2010-11-01 | 2019-12-10 | G-Tech Medical, Inc. | Wearable wireless patches containing electrode pair arrays for gastrointestinal electrodiagnostics |
US9943264B2 (en) | 2012-10-10 | 2018-04-17 | G-Tech Medical, Inc. | Wearable wireless patches containing electrode pair arrays for gastrointestinal electrodiagnostics |
JP2014504902A (en) | 2010-11-22 | 2014-02-27 | プロテウス デジタル ヘルス, インコーポレイテッド | Ingestible device with medicinal product |
USD704856S1 (en) | 2010-12-06 | 2014-05-13 | Medline Industries, Inc. | Medical tray |
US9439599B2 (en) | 2011-03-11 | 2016-09-13 | Proteus Digital Health, Inc. | Wearable personal body associated device with various physical configurations |
US9756874B2 (en) | 2011-07-11 | 2017-09-12 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
WO2015112603A1 (en) | 2014-01-21 | 2015-07-30 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
IN2014MN00183A (en) | 2011-07-21 | 2015-06-19 | Proteus Digital Health Inc | |
US9235683B2 (en) | 2011-11-09 | 2016-01-12 | Proteus Digital Health, Inc. | Apparatus, system, and method for managing adherence to a regimen |
CZ303700B6 (en) * | 2012-01-19 | 2013-03-20 | Vysoká Skola Bánská Technická - Univerzita Ostrava | Capsule-type sensor of bulk material physical and optical quantities and method of measuring bulk material physical and optical quantities |
KR20150038038A (en) | 2012-07-23 | 2015-04-08 | 프로테우스 디지털 헬스, 인코포레이티드 | Techniques for manufacturing ingestible event markers comprising an ingestible component |
US20140028820A1 (en) * | 2012-07-24 | 2014-01-30 | Capso Vision, Inc. | System and Method for Display of Capsule Images and Associated Information |
US11826170B2 (en) | 2012-10-10 | 2023-11-28 | G-Tech Medical, Inc. | Artificial intelligence models for wireless patch data acquisition for gastrointestinal electrodiagnostics |
DK2910013T3 (en) | 2012-10-18 | 2018-08-06 | Proteus Digital Health Inc | Apparatus, system and method for adaptive optimization for power output and transmit power in a power source for a communication device |
WO2014120669A1 (en) | 2013-01-29 | 2014-08-07 | Proteus Digital Health, Inc. | Highly-swellable polymeric films and compositions comprising the same |
WO2014151929A1 (en) | 2013-03-15 | 2014-09-25 | Proteus Digital Health, Inc. | Personal authentication apparatus system and method |
US10175376B2 (en) | 2013-03-15 | 2019-01-08 | Proteus Digital Health, Inc. | Metal detector apparatus, system, and method |
JP6511439B2 (en) | 2013-06-04 | 2019-05-15 | プロテウス デジタル ヘルス, インコーポレイテッド | Systems, devices, and methods for data collection and outcome assessment |
US9796576B2 (en) | 2013-08-30 | 2017-10-24 | Proteus Digital Health, Inc. | Container with electronically controlled interlock |
RU2628404C1 (en) | 2013-09-20 | 2017-08-16 | Протеус Диджитал Хелс, Инк. | Methods, devices and systems of signals receiving and decoding in the presence of noise using the shears and deformation |
JP2016537924A (en) | 2013-09-24 | 2016-12-01 | プロテウス デジタル ヘルス, インコーポレイテッド | Method and apparatus for use with electromagnetic signals received at frequencies that are not accurately known in advance |
US10084880B2 (en) | 2013-11-04 | 2018-09-25 | Proteus Digital Health, Inc. | Social media networking based on physiologic information |
CZ2014679A3 (en) * | 2014-10-06 | 2015-10-21 | Vysoká škola báňská- Technická univerzita Ostrava | Device to sense mechanical-physical and optical values of bulk materials |
US10485444B2 (en) | 2014-10-17 | 2019-11-26 | G-Tech Medical, Inc. | Systems and methods for processing electromyographic signals of the gastrointestinal tract |
US10373523B1 (en) * | 2015-04-29 | 2019-08-06 | State Farm Mutual Automobile Insurance Company | Driver organization and management for driver's education |
US11051543B2 (en) | 2015-07-21 | 2021-07-06 | Otsuka Pharmaceutical Co. Ltd. | Alginate on adhesive bilayer laminate film |
US10512414B2 (en) | 2015-08-29 | 2019-12-24 | G-Tech Medical, Inc. | Apparatus and method for detecting gastrointestinal motor activity during post-operative recovery |
BR112019000861B1 (en) | 2016-07-22 | 2020-10-27 | Proteus Digital Health, Inc | electronic device |
EP3497437B1 (en) * | 2016-08-15 | 2023-03-01 | Royal Melbourne Institute Of Technology | Gas sensor capsule |
GB2554354B (en) * | 2016-09-21 | 2021-06-02 | Vibrant Ltd | Systems for adaptive treatment of disorders in the gastrointestinal tract |
TWI735689B (en) | 2016-10-26 | 2021-08-11 | 日商大塚製藥股份有限公司 | Methods for manufacturing capsules with ingestible event markers |
AU2018282907B2 (en) * | 2017-06-12 | 2023-12-07 | Rani Therapeutics, Llc | Swallowable capsule, system and method for measuring gastric emptying parameters |
US11504024B2 (en) | 2018-03-30 | 2022-11-22 | Vibrant Ltd. | Gastrointestinal treatment system including a vibrating capsule, and method of use thereof |
US11638678B1 (en) | 2018-04-09 | 2023-05-02 | Vibrant Ltd. | Vibrating capsule system and treatment method |
US11510590B1 (en) | 2018-05-07 | 2022-11-29 | Vibrant Ltd. | Methods and systems for treating gastrointestinal disorders |
US11116937B2 (en) | 2018-05-11 | 2021-09-14 | Medline Industries, Inc. | Foley catheter and corresponding single-layer tray packaging system |
AT521597B1 (en) * | 2018-11-13 | 2020-03-15 | Smaxtec Animal Care Gmbh | Method, device and system for determining at least one state variable of the organism of a farm animal |
WO2023064996A1 (en) * | 2021-10-21 | 2023-04-27 | Atmo Biosciences Pty Ltd | Method, program, and apparatus for determining location of ingestible capsule |
WO2024040290A1 (en) * | 2022-08-23 | 2024-02-29 | Atmo Biosciences Limited | Gastroparesis diagnostic method, program, and apparatus |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050065450A1 (en) * | 2003-09-05 | 2005-03-24 | Stuebe Thomas D. | Esophageal function display and playback system and method for displaying esophageal function |
US20050075551A1 (en) * | 2003-10-02 | 2005-04-07 | Eli Horn | System and method for presentation of data streams |
US20080064938A1 (en) * | 2006-09-08 | 2008-03-13 | Semler John R | Method of determining location of an ingested capsule |
Family Cites Families (104)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3683389A (en) * | 1971-01-20 | 1972-08-08 | Corning Glass Works | Omnidirectional loop antenna array |
US3971362A (en) * | 1972-10-27 | 1976-07-27 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Miniature ingestible telemeter devices to measure deep-body temperature |
US3909792A (en) | 1973-02-26 | 1975-09-30 | American Optical Corp | Electrocardiographic review system |
US4008712A (en) * | 1975-11-14 | 1977-02-22 | J. M. Richards Laboratories | Method for monitoring body characteristics |
JPS5519124A (en) * | 1978-07-27 | 1980-02-09 | Olympus Optical Co | Camera system for medical treatment |
JPS5745833A (en) | 1980-09-01 | 1982-03-16 | Taeko Nakagawa | Stomack camera |
US5993378A (en) | 1980-10-28 | 1999-11-30 | Lemelson; Jerome H. | Electro-optical instruments and methods for treating disease |
DE3440177A1 (en) | 1984-11-02 | 1986-05-15 | Friedrich Dipl.-Ing. 8031 Eichenau Hilliges | Television recording and replay device for endoscopy on human and animal bodies |
US4689621A (en) * | 1986-03-31 | 1987-08-25 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Temperature responsive transmitter |
JPH0664243B2 (en) * | 1986-04-30 | 1994-08-22 | オリンパス光学工業株式会社 | Endoscope |
US4989610A (en) * | 1987-11-16 | 1991-02-05 | Spacelabs, Inc. | Method and system of ECG data review and analysis |
US4936823A (en) | 1988-05-04 | 1990-06-26 | Triangle Research And Development Corp. | Transendoscopic implant capsule |
US4844076A (en) * | 1988-08-26 | 1989-07-04 | The Johns Hopkins University | Ingestible size continuously transmitting temperature monitoring pill |
US5050613A (en) * | 1989-09-15 | 1991-09-24 | Imex Corporation | Method and apparatus for vascular testing |
JP2579372B2 (en) | 1989-12-04 | 1997-02-05 | 日本テキサス・インスツルメンツ株式会社 | Low power imaging device |
US5761655A (en) | 1990-06-06 | 1998-06-02 | Alphatronix, Inc. | Image file storage and retrieval system |
JPH04109927A (en) | 1990-08-31 | 1992-04-10 | Toshiba Corp | Electronic endoscope apparatus |
JP2948900B2 (en) | 1990-11-16 | 1999-09-13 | オリンパス光学工業株式会社 | Medical capsule |
JP2643596B2 (en) | 1990-11-29 | 1997-08-20 | 株式会社日立製作所 | Display method of scalar quantity distribution |
JP2768029B2 (en) | 1991-02-19 | 1998-06-25 | 日新電機株式会社 | Digestive system diagnostic device |
US5279607A (en) | 1991-05-30 | 1994-01-18 | The State University Of New York | Telemetry capsule and process |
EP0526064B1 (en) | 1991-08-02 | 1997-09-10 | The Grass Valley Group, Inc. | Video editing system operator interface for visualization and interactive control of video material |
US5384862A (en) | 1992-05-29 | 1995-01-24 | Cimpiter Corporation | Radiographic image evaluation apparatus and method |
US5392072A (en) | 1992-10-23 | 1995-02-21 | International Business Machines Inc. | Hybrid video compression system and method capable of software-only decompression in selected multimedia systems |
JP3020376B2 (en) | 1993-03-26 | 2000-03-15 | サージミヤワキ株式会社 | Internal body identification device for animals |
IL108352A (en) * | 1994-01-17 | 2000-02-29 | Given Imaging Ltd | In vivo video camera system |
US5819736A (en) * | 1994-03-24 | 1998-10-13 | Sightline Technologies Ltd. | Viewing method and apparatus particularly useful for viewing the interior of the large intestine |
JP3631265B2 (en) | 1994-04-27 | 2005-03-23 | オリンパス株式会社 | In-vivo observation device |
US5959673A (en) | 1995-10-05 | 1999-09-28 | Microsoft Corporation | Transform coding of dense motion vector fields for frame and object based video coding applications |
US5838313A (en) | 1995-11-20 | 1998-11-17 | Siemens Corporate Research, Inc. | Multimedia-based reporting system with recording and playback of dynamic annotation |
US5822539A (en) | 1995-12-08 | 1998-10-13 | Sun Microsystems, Inc. | System for adding requested document cross references to a document by annotation proxy configured to merge and a directory generator and annotation server |
US5920317A (en) | 1996-06-11 | 1999-07-06 | Vmi Technologies Incorporated | System and method for storing and displaying ultrasound images |
GB9619470D0 (en) | 1996-09-18 | 1996-10-30 | Univ London | Imaging apparatus |
US5924074A (en) | 1996-09-27 | 1999-07-13 | Azron Incorporated | Electronic medical records system |
US5749908A (en) | 1996-12-18 | 1998-05-12 | Pacesetter, Inc. | Methods and apparatus for annotating data in an implantable device programmer using digitally recorded sound |
US6222547B1 (en) | 1997-02-07 | 2001-04-24 | California Institute Of Technology | Monitoring and analysis of data in cyberspace |
US6346940B1 (en) | 1997-02-27 | 2002-02-12 | Kabushiki Kaisha Toshiba | Virtualized endoscope system |
US6124864A (en) | 1997-04-07 | 2000-09-26 | Synapix, Inc. | Adaptive modeling and segmentation of visual image streams |
US6600496B1 (en) | 1997-09-26 | 2003-07-29 | Sun Microsystems, Inc. | Interactive graphical user interface for television set-top box |
US6219837B1 (en) | 1997-10-23 | 2001-04-17 | International Business Machines Corporation | Summary frames in video |
US6240312B1 (en) * | 1997-10-23 | 2001-05-29 | Robert R. Alfano | Remote-controllable, micro-scale device for use in in vivo medical diagnosis and/or treatment |
US6188403B1 (en) | 1997-11-21 | 2001-02-13 | Portola Dimensional Systems, Inc. | User-friendly graphics generator using direct manipulation |
IL122602A0 (en) | 1997-12-15 | 1998-08-16 | Tally Eitan Zeev Pearl And Co | Energy management of a video capsule |
US6097399A (en) | 1998-01-16 | 2000-08-01 | Honeywell Inc. | Display of visual data utilizing data aggregation |
US6192266B1 (en) | 1998-03-26 | 2001-02-20 | Boston Scientific Corporation | Systems and methods for controlling the use of diagnostic or therapeutic instruments in interior body regions using real and idealized images |
US6115626A (en) | 1998-03-26 | 2000-09-05 | Scimed Life Systems, Inc. | Systems and methods using annotated images for controlling the use of diagnostic or therapeutic instruments in instruments in interior body regions |
JP3855462B2 (en) | 1998-05-29 | 2006-12-13 | 株式会社日立製作所 | Method for editing command sequence with processing time and apparatus using the same |
JP4076003B2 (en) * | 1999-02-19 | 2008-04-16 | 株式会社日立製作所 | Biological light measurement device |
US7116352B2 (en) * | 1999-02-25 | 2006-10-03 | Visionsense Ltd. | Capsule |
US8636648B2 (en) | 1999-03-01 | 2014-01-28 | West View Research, Llc | Endoscopic smart probe |
AU4185800A (en) | 1999-03-30 | 2000-10-16 | Tivo, Inc. | Multimedia program bookmarking system |
GB2352636B (en) | 1999-08-03 | 2003-05-14 | Univ College London Hospitals | Improved passage-travelling device |
US6681003B2 (en) * | 1999-10-05 | 2004-01-20 | Lifecor, Inc. | Data collection and system management for patient-worn medical devices |
JP4472069B2 (en) | 1999-11-10 | 2010-06-02 | オリンパス株式会社 | Medical capsule endoscope |
US6614452B1 (en) | 1999-11-15 | 2003-09-02 | Xenogen Corporation | Graphical user interface for in-vivo imaging |
IL134017A (en) | 2000-01-13 | 2008-04-13 | Capsule View Inc | Camera for viewing inside intestines |
US7039453B2 (en) | 2000-02-08 | 2006-05-02 | Tarun Mullick | Miniature ingestible capsule |
JP4338280B2 (en) | 2000-02-15 | 2009-10-07 | Hoya株式会社 | Capsule endoscope |
JP2001224553A (en) | 2000-02-17 | 2001-08-21 | Asahi Optical Co Ltd | Imaging instrument for capusle endoscope |
KR100798048B1 (en) | 2000-03-08 | 2008-01-24 | 기븐 이미징 리미티드 | A capsule for in vivo imaging |
US6692430B2 (en) | 2000-04-10 | 2004-02-17 | C2Cure Inc. | Intra vascular imaging apparatus |
US6512953B2 (en) | 2000-05-11 | 2003-01-28 | Pacesetter, Inc. | System and method for automatically verifying capture during multi-chamber stimulation |
US6709387B1 (en) | 2000-05-15 | 2004-03-23 | Given Imaging Ltd. | System and method for controlling in vivo camera capture and display rate |
IL163684A0 (en) | 2000-05-31 | 2005-12-18 | Given Imaging Ltd | Measurement of electrical characteristics of tissue |
FR2812293B1 (en) | 2000-07-28 | 2002-12-27 | Rhodia Chimie Sa | METHOD FOR SYNTHESIS OF BLOCK POLYMERS BY CONTROLLED RADICAL POLYMERIZATION |
US8538770B2 (en) | 2000-08-01 | 2013-09-17 | Logical Images, Inc. | System and method to aid diagnoses using cross-referenced knowledge and image databases |
JP2004508757A (en) | 2000-09-08 | 2004-03-18 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | A playback device that provides a color slider bar |
JP4249479B2 (en) | 2000-09-27 | 2009-04-02 | ギブン イメージング リミテッド | Immobilizable in vivo detection device |
US6632175B1 (en) | 2000-11-08 | 2003-10-14 | Hewlett-Packard Development Company, L.P. | Swallowable data recorder capsule medical device |
US6941166B2 (en) * | 2000-11-10 | 2005-09-06 | C.R. Bard, Inc. | Software controlled electrophysiology data management |
WO2002045567A2 (en) | 2000-12-07 | 2002-06-13 | Given Imaging Ltd. | Method and system for use of a pointing device with moving images |
US20020107444A1 (en) | 2000-12-19 | 2002-08-08 | Doron Adler | Image based size analysis |
US7407484B2 (en) * | 2001-04-06 | 2008-08-05 | Medic4All Inc. | Physiological monitoring system for a computational device of a human subject |
EP1382041A1 (en) | 2001-04-17 | 2004-01-21 | Koninklijke Philips Electronics N.V. | Method and system for selecting a position in an image sequence |
US7119814B2 (en) * | 2001-05-18 | 2006-10-10 | Given Imaging Ltd. | System and method for annotation on a moving image |
US7245746B2 (en) | 2001-06-12 | 2007-07-17 | Ge Medical Systems Global Technology Company, Llc | Ultrasound color characteristic mapping |
US6939292B2 (en) * | 2001-06-20 | 2005-09-06 | Olympus Corporation | Capsule type endoscope |
AU2002304266A1 (en) | 2001-06-20 | 2003-01-02 | Given Imaging Ltd. | Motility analysis within a gastrointestinal tract |
US20060184039A1 (en) * | 2001-07-26 | 2006-08-17 | Dov Avni | Apparatus and method for light control in an in-vivo imaging device |
US7219034B2 (en) | 2001-09-13 | 2007-05-15 | Opnet Technologies, Inc. | System and methods for display of time-series data distribution |
JP4347697B2 (en) * | 2002-01-04 | 2009-10-21 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Electric discharge lamp |
US7505062B2 (en) | 2002-02-12 | 2009-03-17 | Given Imaging Ltd. | System and method for displaying an image stream |
JP4109927B2 (en) | 2002-08-20 | 2008-07-02 | セイコークロック株式会社 | Radio correction watch and method |
US20040054294A1 (en) * | 2002-09-18 | 2004-03-18 | Ramseth Douglas J. | Method and apparatus for interactive annotation and measurement of time series data with centralized analysis and review |
US20040066398A1 (en) | 2002-10-03 | 2004-04-08 | Koninklijke Philips Electronics N.V | System and method for removing, trimming and bookmarking images of an ultrasound image sequence |
WO2004036390A2 (en) * | 2002-10-18 | 2004-04-29 | Trustees Of Boston University | Patient activity monitor |
US20040103000A1 (en) * | 2002-11-26 | 2004-05-27 | Fori Owurowa | Portable system and method for health information storage, retrieval, and management |
US20050038680A1 (en) * | 2002-12-19 | 2005-02-17 | Mcmahon Kevin Lee | System and method for glucose monitoring |
US20040184639A1 (en) | 2003-02-19 | 2004-09-23 | Linetech Industries, Inc. | Method and apparatus for the automated inspection and grading of fabrics and fabric samples |
US6786406B1 (en) * | 2003-03-28 | 2004-09-07 | Peter A. Maningas | Medical pathways rapid triage system |
US7557805B2 (en) | 2003-04-01 | 2009-07-07 | Battelle Memorial Institute | Dynamic visualization of data streams |
JP4493386B2 (en) | 2003-04-25 | 2010-06-30 | オリンパス株式会社 | Image display device, image display method, and image display program |
CN100431475C (en) * | 2003-04-25 | 2008-11-12 | 奥林巴斯株式会社 | Device, method and program for image processing |
JP3810381B2 (en) | 2003-04-25 | 2006-08-16 | オリンパス株式会社 | Image display device, image display method, and image display program |
US7295346B2 (en) | 2003-06-23 | 2007-11-13 | Xeorx Corporation | Methods and apparatus for antialiasing using selective implementation of logical and averaging filter operations |
US8790275B2 (en) * | 2004-05-17 | 2014-07-29 | Given Imaging (Los Angeles) Llc | Analysis and visualization methods using manometry data |
US20060149140A1 (en) * | 2005-01-06 | 2006-07-06 | Paulla Eldridge | Automated system for patient diagnosis and crisis management system |
IL177045A (en) * | 2005-07-25 | 2012-12-31 | Daniel Gat | Device, system and method of receiving and recording and displaying in-vivo data with user entered data |
US7296733B2 (en) * | 2005-09-02 | 2007-11-20 | Voikex, Inc. | Device and methods for storing and tracking pregnancy progress |
US20070060798A1 (en) * | 2005-09-15 | 2007-03-15 | Hagai Krupnik | System and method for presentation of data streams |
US20070127793A1 (en) * | 2005-11-23 | 2007-06-07 | Beckett Bob L | Real-time interactive data analysis management tool |
JP5015515B2 (en) | 2006-08-02 | 2012-08-29 | 伊藤超短波株式会社 | Muscle training equipment |
US8303573B2 (en) * | 2007-10-17 | 2012-11-06 | The Invention Science Fund I, Llc | Medical or veterinary digestive tract utilization systems and methods |
US20090275850A1 (en) * | 2008-04-30 | 2009-11-05 | Mehendale Anil C | Electrocardiographic (ECG) Data Analysis Systems and Methods |
-
2009
- 2009-06-12 AU AU2009260834A patent/AU2009260834B2/en not_active Ceased
- 2009-06-12 WO PCT/US2009/003533 patent/WO2009154707A2/en active Application Filing
- 2009-06-12 US US12/456,151 patent/US9538937B2/en active Active
- 2009-06-12 CA CA2724890A patent/CA2724890A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050065450A1 (en) * | 2003-09-05 | 2005-03-24 | Stuebe Thomas D. | Esophageal function display and playback system and method for displaying esophageal function |
US20050075551A1 (en) * | 2003-10-02 | 2005-04-07 | Eli Horn | System and method for presentation of data streams |
US20080064938A1 (en) * | 2006-09-08 | 2008-03-13 | Semler John R | Method of determining location of an ingested capsule |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2010235197B2 (en) * | 2009-03-31 | 2014-10-16 | Covidien Lp | Method of determining body exit of an ingested capsule |
WO2013120184A1 (en) * | 2012-02-17 | 2013-08-22 | Micropharma Limited | Ingestible medical device |
US10172598B2 (en) | 2012-02-17 | 2019-01-08 | Progenity, Inc. | Ingestible medical device |
US11007356B2 (en) | 2018-11-19 | 2021-05-18 | Progenity, Inc. | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract |
US11439802B2 (en) | 2018-11-19 | 2022-09-13 | Biora Therapeutics, Inc. | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract |
Also Published As
Publication number | Publication date |
---|---|
WO2009154707A3 (en) | 2010-04-01 |
US9538937B2 (en) | 2017-01-10 |
AU2009260834A1 (en) | 2009-12-23 |
CA2724890A1 (en) | 2009-12-23 |
AU2009260834B2 (en) | 2014-10-09 |
US20090318783A1 (en) | 2009-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2009260834B2 (en) | System and method of evaluating a subject with an ingestible capsule | |
US10888254B2 (en) | Apparatus, systems, and methods for determining and displaying pre-event and post-event analyte concentration levels | |
EP3297531B1 (en) | Apparatus for guiding medical care based on sensor data from the gastrointestinal tract | |
des Varannes et al. | Simultaneous recordings of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo) | |
Tran et al. | Evaluation of regional and whole gut motility using the wireless motility capsule: relevance in clinical practice | |
CN102947833B (en) | System and method for optimizing insulin dose | |
ES2330897T3 (en) | EVALUATION PROCEDURE FOR THE PROCESSING OF A CONCENTRATION SIGN IN GLUCOSE. | |
RU2749187C2 (en) | Computer-implemented method and portable apparatus for analysis of glucose control data indicating glucose level in bodily fluid | |
JPS62281924A (en) | Portable apparatus for judging upper gastrointestinal function by ph value and its clinical use | |
KR20140133852A (en) | Connector Interface System for Data Acquisition | |
EP2413786B1 (en) | Method of determining body exit of an ingested capsule | |
JP2011523478A (en) | Specimen measurement and management device and related method | |
JP2009028352A (en) | Sleep information providing system | |
US20080287833A1 (en) | Method of evaluating gastroparesis using an ingestible capsule | |
CN110786865A (en) | System and method for controlling blood glucose using personalized histograms | |
Dent et al. | Esophageal motility and reflux testing: state-of-the-art and clinical role in the twenty-first century | |
US20090281395A1 (en) | Method of determining the slow wave of a gastrointestinal tract | |
ES2753356T3 (en) | A procedure and device for determining a patient's body fluid glucose level, and a computer program product | |
Pannala et al. | Devices for esophageal function testing | |
WO2022114010A1 (en) | Information processing device, information processing method, and information processing program | |
Ravi et al. | New technologies to evaluate esophageal function | |
Kim | Diagnostic Tests and Interpretations Before Anti-reflux Surgery | |
Vakil | Esophageal Manometry and Esophageal pH Testing | |
Zhang et al. | Non-invasive measurement of pan-colonic pressure over a whole digestive cycle: clinical applications of a capsule-style manometric system | |
Burgers et al. | ColoniC ManoMetry |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09767020 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009260834 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2009260834 Country of ref document: AU Date of ref document: 20090612 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2724890 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09767020 Country of ref document: EP Kind code of ref document: A2 |